187 related articles for article (PubMed ID: 997590)
41. Metabolic disposition of isoxicam in man, monkey, dog, and rat.
Borondy PE; Michniewicz BM
Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211
[TBL] [Abstract][Full Text] [Related]
42. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
Obermeier K; Niebch G; Thiemer K
Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
[TBL] [Abstract][Full Text] [Related]
43. Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.
Tocco DJ; Breault GO; Zacchei AG; Steelman SL; Perrier CV
Drug Metab Dispos; 1975; 3(6):453-66. PubMed ID: 1220
[TBL] [Abstract][Full Text] [Related]
44. [Metabolism and pharmacokinetics of piprozoline in the rat, dog and man. 1. Studies with the radioactively-labeled substance].
Vollmer KO; Hodenberg AV; Poisson A; Bode R; Schauerte E
Arzneimittelforschung; 1977; 27(2b):502-8. PubMed ID: 577412
[TBL] [Abstract][Full Text] [Related]
45. Metabolic fate of premazepam, a new anti-anxiety drug, in the rat and the dog.
Assandri A; Barone D; Ferrari P; Perazzi A; Ripamonti A; Tuan G; Zerilli LF
Drug Metab Dispos; 1984; 12(2):257-63. PubMed ID: 6144494
[TBL] [Abstract][Full Text] [Related]
46. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man.
Midgley I; Chasseaud LF; Taylor IW; Walmsley LM; Fowkes AG; Darragh A; Lambe RF; Bonn R
Xenobiotica; 1985 Nov; 15(11):965-77. PubMed ID: 4082636
[TBL] [Abstract][Full Text] [Related]
47. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
48. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
[TBL] [Abstract][Full Text] [Related]
49. Metabolic disposition of enciprazine, a non-benzodiazepine anxiolytic drug, in rat, dog and man.
Scatina JA; Lockhead SR; Cayen MN; Sisenwine SF
Xenobiotica; 1991 Dec; 21(12):1591-604. PubMed ID: 1686125
[TBL] [Abstract][Full Text] [Related]
50. Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog.
Pellegatti M; Grossi P; Ayrton J; Evans GL; Harker AJ
Xenobiotica; 1990 Aug; 20(8):765-77. PubMed ID: 2219960
[TBL] [Abstract][Full Text] [Related]
51. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
52. The fate of saccharin impurities: the excretion and metabolism of toluene-2-sulphonamide in man and rat.
Renwick AG; Ball LM; Corina DL; Williams RT
Xenobiotica; 1978 Aug; 8(8):461-74. PubMed ID: 695690
[TBL] [Abstract][Full Text] [Related]
53. Physiological disposition and metabolism of (3H)bitolterol in man and dog.
Shargel L; Dorrbecker SA
Drug Metab Dispos; 1976; 4(1):72-8. PubMed ID: 3404
[TBL] [Abstract][Full Text] [Related]
54. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse.
Weidolf L; Borg KO; Hoffmann KJ
Xenobiotica; 1984 Aug; 14(8):657-66. PubMed ID: 6495759
[TBL] [Abstract][Full Text] [Related]
55. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
56. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
[TBL] [Abstract][Full Text] [Related]
57. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
58. Disposition of bemitradine, a renal vasodilator and diuretic, in man.
Walls CM; Gray A; Vose CW; Robinson Y; Lopez N; Brownsill RD; Steiner JA
Xenobiotica; 1988 Dec; 18(12):1413-23. PubMed ID: 3245233
[TBL] [Abstract][Full Text] [Related]
59. The metabolic fate of the coronary dilator 4-(3,4,5,-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl)-piperazine in the rat, dog and man.
Chasseaud LF; Hawkins DR; Fry BJ; Lewis JD; Saggers VH; Sword IP
Xenobiotica; 1974 Jul; 4(7):393-407. PubMed ID: 4432531
[No Abstract] [Full Text] [Related]
60. The disposition of [14C]iprindole in man, dog, miniature swine, rhesus monkey and rat.
Sisenwine SF; Tio CO; Ruelius HW
Xenobiotica; 1979 Apr; 9(4):237-46. PubMed ID: 113942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
